Preblick Ryan sold INDV
March 3, 2026 · Form 4 insider transaction
Preblick Ryan sold 113,510 shares of Indivior Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
113,510
Price
N/A
Total value
N/A
InsiderPreblick Ryan
Role—
SecurityPerformance Stock Units
Transaction codeM: Option exercise
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.; Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period.